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Abstract
Background: Sustainable Development Goal (SDG) 2.2 calls for an end to all forms of malnutrition, with 2025
targets of a 40% reduction in stunting (relative to 2012), for wasting to occur in less than 5% of children, and for a
50% reduction in anaemia in women (15–49 years). We assessed the likelihood of countries reaching these targets
by scaling up proven interventions and identified priority interventions, based on cost-effectiveness.
Methods: For 129 countries, the Optima Nutrition model was used to compare 2019–2030 nutrition outcomes
between a status quo (maintained intervention coverage) scenario and a scenario where outcome-specific
interventions were scaled up to 95% coverage over 5 years. The average cost-effectiveness of each intervention was
calculated as it was added to an expanding package of interventions.
Results: Of the 129 countries modelled, 46 (36%), 66 (51%) and 0 (0%) were on track to achieve the stunting,
wasting and anaemia targets respectively. Scaling up 18 nutrition interventions increased the number of countries
reaching the SDG 2.2 targets to 50 (39%), 83 (64%) and 7 (5%) respectively. Intermittent preventative treatment of
malaria during pregnancy (IPTp), infant and young child feeding education, vitamin A supplementation and lipid-
based nutrition supplements for children produced 88% of the total impact on stunting, with average costs per case
averted of US$103, US$267, US$556 and US$1795 when interventions were consecutively scaled up, respectively.
Vitamin A supplementation and cash transfers produced 100% of the total global impact on prevention of wasting,
with average costs per case averted of US$1989 and US$19,427, respectively. IPTp, iron and folic acid supplementation
for non-pregnant women, and multiple micronutrient supplementation for pregnant women produced 85% of the
total impact on anaemia prevalence, with average costs per case averted of US$9, US$35 and US$47, respectively.
Conclusions: Prioritising nutrition investment to the most cost-effective interventions within the country context can
maximise the impact of funding. A greater focus on complementing nutrition-specific interventions with nutrition-
sensitive ones that address the social determinants of health is critical to reach the SDG targets.
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Background
Undernutrition contributes to an estimated 45% of child
deaths globally [1]. Stunting (height-for-age more than
two standard deviations below the World Health
Organization (WHO) Child Growth Reference Standards
median) and wasting (weight-for-height more than two
standard deviations below the WHO Child Growth Stan-
dards median) are associated with higher risk of severe ill-
ness and death. Other forms of undernutrition affect child
brain development, impairing learning and future earning
capacity [2]. Together, these conditions increase child
mortality, exacerbate poverty, create entrenched intergen-
erational disadvantage and hinder the economic future of
a country. The Sustainable Development Goals (SDGs)
target 2.2 calls for ending malnutrition in all its forms [3].
Progress is tracked by four nutritional indicators; stunting
and wasting levels in children under 5 years of age, an-
aemia in women of reproductive age (15–49 years) and
overweight among children under five. There is an aspir-
ation to achieve, by 2025, a 40% relative reduction in
stunting (to a global prevalence of approximately 15%), a
reduction in child wasting to < 5% prevalence, and a 50%
relative reduction in anaemia in women (to a global preva-
lence of approximately 15%), with 2012 as the baseline
year. [3]. Several analyses have shown that despite im-
provements in child stunting and wasting over the last
two decades [4], most countries are not on track to reach
the SDG 2.2 undernutrition targets [5].
Today there exists a suite of proven nutrition interven-
tions that address the immediate causes of undernutrition,
widely referred to as “nutrition-specific interventions”. It
is well-established that non-nutritional factors affect nutri-
tional status, including subclinical inflammation and un-
treated infections, environmental pathogen exposure,
gender inequality and women’s lack of agency and em-
powerment. Policies and interventions to address these
underlying factors, such as health systems strengthening,
improved water, sanitation and hygiene (WASH) and
women’s empowerment, are called “nutrition-sensitive”
because they address underlying social, environmental and
health-related nutrition determinants, and improvements
in nutritional status may result when these interventions
are implemented at scale (as illustrated in UNICEF’s con-
ceptual framework [6]).
Evidence for the impact of nutrition-specific interven-
tions comes from systematic reviews and meta-analyses
of findings from randomised controlled efficacy and ef-
fectiveness studies that are summarised in the WHO
guidelines [7, 8] and multiple Lancet nutrition series
(2008 [9], 2013 [10], 2019 [11]). The cost and marginal
impact of policies and interventions to address under-
lying determinants is less amenable to controlled study,
and information about their role is primarily based on
quantitative decomposition analyses of cross-sectional
data collected over time [12–21]. This asymmetry in the
evidence base makes it difficult to model and compare
the cost-effectiveness of these different types of interven-
tions or to measure their complementary impacts; how-
ever, in recent years, the number of studies to address this
evidence gap is increasing. An additional challenge is that
data on coverage of most proven nutrition interventions is
lacking, making it difficult to assess baselines and progress
towards implementing interventions [22].
Previous work has estimated the cost and impact of
scaling up evidence-based nutrition interventions. In
2010, Horton and colleagues [23] estimated that it would
cost US$10.3 billion per annum globally to scale up the
13 nutrition interventions from the 2008 Lancet series
[9], and that doing so could reduce stunting by 20% and
the prevalence of severe acute malnutrition by 50%. In
2013, Bhutta and colleagues [10] estimated that it would
cost US$9.6 billion per annum to scale up 10 nutrition-
specific interventions in 34 countries (90% of the world’s
stunting burden), and that this could reduce stunting by
20% and the prevalence of severe wasting by 61%. In
2017, Shekar and colleagues [24] provided an investment
framework for reaching the SDG 2.2 undernutrition targets
(and the global nutrition target of 50% of infants < 6
months exclusively breastfed by 2025 [25]). They estimated
that the world needs US$70 billion over 10 years to invest
in high-impact nutrition-specific interventions in order to
reach these targets, combined with continued improve-
ments in WASH and other underlying determinants [26].
Investment cases and costing estimates for nutrition
interventions are vital for their adoption; however,
budget constraints mean that countries will not be able
to scale up all available nutrition interventions. Deci-
sions must be made about how to prioritise interven-
tions, and countries will benefit from knowing what the
most cost-effective strategies are to maximise the impact
of limited funds. Optima Nutrition [27] is a mathemat-
ical model that estimates the impact of scaling up com-
binations of 18 different nutrition interventions on
stunting, wasting and mortality in children under five
and anaemia in women of reproductive age. These inter-
ventions are included in the model based on systematic
reviews, meta-analyses and the findings of multiple Lan-
cet series; each intervention has been shown in isolation
to lead to improved nutrition outcomes. The model also
includes an economic component and can generate aver-
age cost-effectiveness estimates for interventions.
This first aim of this study was to expand the scope of
previous analyses by estimating the progress that could
be made towards the SDG 2.2 undernutrition targets by
scaling up 18 nutrition interventions (for which there is
currently evidence of effectiveness) within 129 individual
low- and middle-income countries (LMICs). The second
aim was to estimate which interventions countries
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should prioritise, to provide countries guidance on how
to maximise impact when investment is limited.
Methods
The Optima Nutrition model
The Optima Nutrition model tracks the number of
women of reproductive age (15–49 years) in a popula-
tion, who can become pregnant and give birth. After
birth, children are tracked until 5 years of age across five
age bands and are categorised according to their
mother’s breastfeeding practices, family economic status,
height-for-age (stunting) status, weight-for-height (wast-
ing) status and anaemia status (Additional file 1: Fig. A1)
[27–49]. Children in the model can die from a range of
specific causes, with the relative risks of dying from each
cause related to the child’s breastfeeding, stunting, wast-
ing and anaemia status according to global published
estimates.
Several risk factors for stunting in children are mod-
elled: birth outcomes (preterm birth and/or a child being
born small for gestational age [SGA]), stunting at a
younger age band, sub-optimal feeding practices (age-ap-
propriate breastfeeding and complementary foods) and
incidence of diarrhoea (Additional file 1: Fig. A2). In
addition, anaemia in women of reproductive age is mod-
elled to be a risk factor for sub-optimal birth outcomes,
birth outcomes and diarrhoea incidence are modelled to
be risk factors for wasting and sub-optimal breastfeeding
is modelled to be a risk factor for diarrhoea incidence.
In the model, interventions can improve nutritional
outcomes directly or indirectly by reducing risk factors.
For example, changes to breastfeeding practices can re-
duce diarrhoea incidence which indirectly reduces stunt-
ing. Changing the coverage of an intervention among its
target population leads to changes in projected nutrition
outcomes based global estimates of intervention effect-
iveness (Additional file 1: Fig. A2). The cost of achieving
a given intervention coverage is calculated by multiply-
ing the number of beneficiaries by the intervention’s es-
timated unit cost per beneficiary (see below).
Eighteen nutrition interventions were considered in
this study based on the available literature and global
recommendations (Tables 1, 2, and 3). These include
various nutrition supplements for pregnant women,
micronutrient supplements for children under five, treat-
ment of severe acute malnutrition for children, lipid-
based nutrition supplements for children 6–23months
at risk of food insecurity and/or poor growth, treatment
of diarrhoea for children, nutrition education and inter-
ventions for reducing malaria.
A detailed model description is available in Add-
itional file 1, as well as the Optima Nutrition user
guide [80].
Population and epidemiological data
For 129 countries (selected based on data availability),
population and epidemiological data inputs, including
baseline data on stunting, wasting and anaemia, were
sourced from global datasets and are summarised in Add-
itional file 1, Table B1. The main sources were Demo-
graphic and Health Survey (DHS) data [37], Multiple
Indicator Cluster Survey (MICS) reports [81], the World
Bank Group [32, 33], WHO [82], United Nations Joint
Child Malnutrition Estimates (UN-JME) [38], the Global
Burden of Disease study [39] and the academic literature
[41, 83]. Where country-specific estimates of epidemio-
logical data were not available, estimates (based on re-
gional averages) were taken from the Lives Saved Tool
(LiST) [28, 29, 34]
The SDG baseline year (2012) prevalence of stunting
and wasting in children were taken from the UN-JME [38]
and baseline prevalence of anaemia in women was taken
from the Global Burden of Disease study [39]. Annual
rates of reduction in undernutrition for each country were
obtained from the 2017 Global Burden of Disease SDG in-
dicator projections [39] and applied to baseline (2012) es-
timates. The Global Burden of Disease study uses
statistical methods to project each indicator based on past
trends (1990–2017), correlates of these trends with socio-
economic development factors, and expected trends in
these socioeconomic development factors [84].
Country-specific inputs are provided in Additional file 2.
Intervention coverage data
The coverage of interventions (Table 2) was estimated
for 2018 for each country from DHS [37] and MICS [81]
data. For interventions not directly contained in these
surveys, estimates were taken from the LiST [34] model,
which creates coverage estimates based on other nation-
ally representative household surveys. For interventions
not in DHS, MICS or LiST, baseline coverage was mod-
elled to be zero.
Intervention cost data
The unit costs of interventions are difficult to estimate
because many interventions are integrated within health
systems and delivered simultaneously with other health
services. Therefore, for this study, we made simple esti-
mates of the country-specific unit costs of each interven-
tion (i.e., the cost per beneficiary) that included costs
associated with eight different domains. These were the
costs associated with commodities, supply chain and
health provider time, as well as fractional costs associ-
ated with the additional infrastructure/equipment, health
information systems, health financing policy, governance
and additional health programme costs that would be re-
quired for their expansion.
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Table 1 Intervention target populations and effects
Target populations and effects
Intervention Target population Effects Source / Effect sizes
Cash transfers
(unconditional)
Children below the poverty
line
Reduces the incidence of
SAM
Reduces the incidence of
MAM
RRR = 0.32 (0.16-0.61) for SAM incidence
RRR = 0.40 (0.23-0.68) for MAM incidence [Langendorf et
al. 2014, PLoS Med [50], Niger study comparing super




Pregnant women (at birth,
but impact is for children <1
month)
Reduces anaemia RRR = 0.53 (0.40-0.70) for being anaemic [Hutton and
Hassan, 2007 Jama [51]]
Infant and young child
feeding (IYCF) education
Home/community promotion for children 0-23 months:
For children < 1 months Increases exclusive
breastfeeding
OR = 2.17 (1.84-2.56) for exclusive breastfeeding [Sinha et
al. 2017 J Nutr [52] for interventions delivered in home or
community settings in low- and middle-income countries]
For children < 6 months Increases exclusive
breastfeeding
OR = 2.48 (1.99-3.09) for exclusive breastfeeding [Sinha et
al. 2017 J Nutr [52] for interventions delivered in home or
community settings in low- and middle-income countries]
For children 6-23 months Increases age-appropriate
(partial) breastfeeding
OR = 1.82 (1.36-2.45) for age-appropriate breastfeeding;
[Sinha et al. 2017 J Nutr [52]]
For children 6-23 months Promotion of appropriate
complementary feeding
reduces odds of stunting
OR = 0.77 for stunting; [Panjwani et al. 2017 J Nutr [53]
food secure population with nutrition education or
counselling compared to receiving no intervention]
Immediate initiation of
breastfeeding
Children < 1 month Increases exclusive
breastfeeding
Reduces deaths due to
prematurity
OR = 1.50 (1.26-1.78) for exclusive breastfeeding in children
< 1 month.
OR = 1.39 (1.11-1.74) for exclusive breastfeeding in children
1-6 months [Boundy et al. 2016, Pediatrics [54]]
RRR = 0.49 (0.29-0.82) for mortality due to prematurity
[Lawn et al. 2010, I J Emi 2010 [55]]
Lipid-based nutrition
supplements
Children 6-23 months old
who live in households
below the poverty line
Reduces the odds of stunting
Reduces the incidence of
SAM
Reduces the incidence of
MAM
Reduces anaemia
OR = 0.89 for stunting [Panjwani et al. 2017 J Nutr [53]
food insecure with supplementation compared to no
supplementation]
RRR = 0.915 for SAM and MAM incidence [based on
Panjwani et al. 2017 J Nutr [53] food insecure with
supplementation compared to no supplementation]
RRR = 0.69 (0.60-0.78) for anaemia [De-Regil et al. 2013





(different quantity by age)
Reduces diarrhoea mortality RRR = 0.24 (0.15-0.38) for diarrhoea mortality. Calculated as
RRR = 0.31 (0.20-0.49) for ORS [Munos, et al. 2010, I J Epi
[57]], with additional RRR of 0.77 due to the addition of
zinc [Walker & Black 2010, I J Epi [58]]
Public provision of
complementary foods
Children 6-23 months old
who live in households
below the poverty line
Reduces the odds of stunting
Reduces the incidence of
SAM
Reduces the incidence of
MAM
OR = 0.89 for stunting [Panjwani et al. 2017 J Nutr [53]
food insecure with supplementation compared to no
supplementation]
RRR = 0.915 for SAM and MAM incidence [based on
Panjwani et al. 2017 J Nutr [53] food insecure with
supplementation compared to no supplementation]
Treatment of severe
acute malnutrition (SAM)
Children experiencing SAM Increases recovery from
episode
78% recovery for wasting among children receiving
intervention [Bhutta et al. 2013, Lenters et al. 2013 [10, 59]].
Note that this intervention is defined as treating children
until they reach a weight-for-height of three standard
deviations below the WHO Child Growth Standards
median, at which point their mortality risks are significantly
reduced but they are still defined as being wasted (i.e.
children who are severely wasted are treated to become
only moderately wasted, but wasted nonetheless).
Vitamin A
supplementation
Children 6-59 months Reduces diarrhoea incidence
mortality
RRR = 0.85 (0.82-0.87) for diarrhoea incidence [Imdad et al.
2017, Cochrane review [60]]
RRR = 0.88 (0.79-0.98) for diarrhoea-specific mortality
[Imdad et al. 2017, Cochrane review [60]]
Balanced energy-protein
supplementation
Pregnant women below the
poverty line
Reduces risk of small for
gestational age (SGA) birth
RRR = 0.79 (0.69-0.90) for SGA birth outcomes [Ota et al.
2015, The Cochrane Library [61]]
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An ingredient-based approach was used to estimate
global commodity costs (estimated from either the
WHO International Drug Price Indicator Guide [68] or
UNICEF supply cost estimates [71]) and country-specific
health provider time requirements (taken from the One-
Health tool [66] and Bhutta et al. (2013) supplement
[10], with per capita gross domestic product (GDP) for
each country used as a country-specific proxy for salary).
Country-specific supply chain costs were estimated
similarly to Stenberg and colleagues’ [70], who grouped
73 countries into five categories based on “Logistics Sys-
tem Condition”, and estimated a mark-up percentage to
apply to commodities for countries in each group (ran-
ging from 8 to 50% for drugs and other commodities
and 14–63% specifically for insecticide-treated bednets).
The additional countries in this study were allocated
into the five groups by determining an approximate
range of GDP per capita for each group (higher GDP
per capita is assumed to be associated with better logis-
tics system conditions).
The fractional costs associated with the remaining five
domains were estimated based on Stenberg and col-
leagues’ [85] work estimating the financing needs of
health system expansion to achieve universal health care.
They estimated that costs associated with infrastruc-
ture and equipment, health information systems,
health financing policy, governance and additional
health programme costs would comprise 51% of the
total costs (i.e. commodities, health provider time and
supply chain costs only account for 49% of all costs).
Therefore, the overall (country-specific) unit cost for
each intervention was calculated by inflating the com-
modity, health provider time and supply chain costs
by ~ 100%.
Costs are presented in 2017 US$ with details for each
intervention in Table 3. Discounting is not included.
Status quo scenario: maintained existing investment
The model was run without changes to intervention
coverage, thus including only continued current trends
in stunting and wasting in children and anaemia in
women (based on annual rates of reduction for each
country, obtained from the 2017 Global Burden of Dis-
ease SDG indicator projections [78] and applied to base-
line (2012) estimates). The models were projected from
2019 to 2030, and progress was measured against the
SDG targets.
Table 1 Intervention target populations and effects (Continued)
Target populations and effects
Intervention Target population Effects Source / Effect sizes
outcomes
Calcium supplementation Pregnant women Reduces maternal mortality
(hypertensive disorders)
Reduces pre-term births
RRR = 0.80 (0.66-0.98) for maternal mortality [Hofmeyr et al.
2018 Cochrane review [62]]
RRR = 0.76 (0.60-0.97) for preterm birth [Hofmeyr et al.
2018 Cochrane review [62]]
Iron and folic acid
supplementation




RRR = 0.33 (0.16-0.69) for anaemia in pregnant women
[Pena-Rosas et al, Cochrane Database Reviews 2015 [63]]
RRR = 0.73 (0.56-0.95) for anaemia in non-pregnant
women [Fernandez-Gaxiola & De-Regil 2011, Cochrane




Pregnant women in areas
where there is malaria risk
Reduces anaemia
Reduces SGA birth outcomes
RRR = 0.83 (0.74-0.93) for being anaemic [Radeva-Petrova
et al. 2014, The Cochrane Library [65]]
RRR = 0.65 (0.55-0.77) for SGA birth outcomes [Eisele et al.
2010, I J Epi [66]]
Multiple micronutrient
supplementation
Pregnant women Reduces anaemia and risk of
SGA birth outcomes
RRR = 0.33 (0.16-0.69) for anaemia in pregnant women
[Pena-Rosas et al, Cochrane Database Reviews 2015 [63]]
RRR = 0.92 (0.88-0.97) for SGA births [Keats et al. 2019
Cochrane Database Reviews [67]]





OR = 0.976 (0.975-0.978) for being anaemic [Barkley et al.
2015, B J Nutrition [68]]
RRR = 0.87 (0.84-0.89) of neonatal mortality [prevention of






OR = 0.976 (0.975-0.978) for being anaemic [Barkley et al.
2015, B J Nutrition [68]]
Long-lasting insecticide-
treated bed nets
Everyone in areas where
there is malaria risk
Reduces anaemia
Reduces SGA birth outcomes
RRR = 0.83 (0.74-0.93) for anaemia [Radeva-Petrova et al.
2014, The Cochrane Library [65]]
RRR = 0.65 (0.55-0.77) for SGA birth outcomes [Eisele et al.
2010, Int J Epi [66]]
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[Between countries: median; inter-quartile
range (IQR) and range between countries]
Low income country (LC), lower-middle
income country (LMC) and upper-middle




0% Not available; set to 0% at baseline.
Delayed umbilical cord
clamping
0% Not available; set to 0% at baseline.
Infant and young child
feeding education
30.3% [Between countries: median=26%; IQR=0-49.4%;
range=0-89.6%]
LC average=22.6%, LMC average=38%, UMC
average=28.4%
LiSTa [34]. The target population for IYCF education was
taken to be all children 0-23 months. Note: Assumed to be
coverage of “Complementary feeding – education only”.
Immediate initiation of
breastfeeding
0% Not available; set to 0% at baseline.
Lipid-based nutrient
supplements
0% Not available; set to 0% at baseline.
Oral rehydration solution +
Zinc
6.6% [Between countries: median=0.2%; IQR=0-8.1%;
range=0-50.7%]





30% [Between countries: median=25.3%; IQR=0-
49.4%; range=0-89.6%]
LC average=22%, LMC average=37.5%, UMC
average=28.4%
LiSTa [34]. Note: Assumed to be coverage of
“Complementary feeding – education and
supplementation”.
Treatment of SAM 4.7% [Between countries: median=0%; IQR=0-1.9%;
range=0-98%]
LC average=12.2%, LMC average=4.4%, UMC
average=0%
LiST [34]. Assuming treatment only for children with weight-
for-height more than three standard deviations below the
WHO Child Growth Standards median (i.e. no management
of moderate acute malnutrition).
Note: LiST states “Coverage data for this indicator are not
typically available. Currently set at 0 for baseline; user should
enter local data if possible and available.” Where available in
the tool, values for some countries have been used.
Vitamin A supplementation 43.9% [Between countries: median=48.8%; IQR=9-
67.5%; range=0-99%]
LC average=71.2%, LMC average=51.7%, UMC
average=18.7%




0% Not available; set to 0% at baseline.
Calcium supplementation 0% Not available; set to 0% at baseline.
Iron and folic acid
supplementation for
pregnant women
17.2% [Between countries: median=4.5%; IQR=0-
32.9%; range=0-81.5%]
LC average=20.6%, LMC average=22%, UMC
average=10.7%
LiSTa [34]. Note: Assumed to be coverage of iron
supplementation.








22.8% [Between countries: median=17.7%; IQR=0-
36.9%; range=0-78.8%]
LC average=30.8%, LMC average=19.1%, UMC
average=5.1%
LiSTa [34]; only includes countries with malaria risk.
Multiple micronutrient
supplementation
0% Not available; set to 0% at baseline.
Iron and folic acid
fortification (wheat, maize
or rice)
50% Global estimate from Shekar et al. investment framework for
nutrition (2017) [24]
Note: Authors state “Baseline coverage of fortification
among staple foods (wheat, maize and rice) is based on the
existence of legislation status for foods fortified in respective
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Maximum impact scenario
For each country, a projection was run where a 5-year
period was used to linearly scale up all interventions
from their baseline estimated coverage in 2019 to 95%
coverage of their target population in 2024, which was
maintained in the model until 2030. The effect sizes of
interventions were assumed to be the same across coun-
tries as insufficient evidence is available on how they
vary by setting.
Intervention expansion pathways
For each country, scenarios were run with each of the 18
interventions scaled up one at a time to 95% coverage
over a 5-year period (2019–2024) and maintained until
2030. In each scenario, the total additional cost and im-
pact on each indicator (stunting, wasting, anaemia) was
recorded and compared to the status quo, with the aver-
age cost-effectiveness of each intervention calculated as
the additional cost divided by the number of cases
averted over the period 2019–2030 (e.g. average cost per
stunting case averted). For each country and indicator,
the single most cost-effective intervention was identified.
To identify the second most cost-effective interven-
tion, the results above are inadequate as the effects of
scaling interventions together will not be additive. This
is because intervention effectiveness measures are based
on relative reductions in nutritional outcomes, and so to
avoid overestimating combined impact, the second inter-
vention is modelled against a new baseline where the
first intervention has already reduced a risk factor or
outcome. This is consistent with other nutrition models
[29, 86]. Therefore, to identify the next most cost-
effective intervention for each indicator, the process
above was repeated but with each of the remaining 17
interventions scaled up one at a time to 95% coverage,
alongside the most cost-effective intervention, with
outcomes compared to the scenario of only the most
cost-effective intervention being scaled up.
This methodology was repeated to identify a sequence
of interventions for each indicator that represent a pri-
oritisation for inclusion in an overall package of
interventions.
Uncertainty bounds
Univariate uncertainty analyses were conducted to gen-
erate uncertainty intervals for the estimated impact (ob-
tained by running projections using the lower and upper
bounds of their effect size estimates) and costs (lower
bounds based on commodity costs of interventions only,
and upper bounds assuming double the non-commodity
costs) of all interventions and countries.
Sensitivity analyses
Univariate sensitivity analyses were used to explore a
variety of alternate analyses including the following: the
possible impact if only nutrition-sensitive interventions
were considered (i.e. excluding cash transfers, intermit-
tent preventative treatment of malaria during pregnancy
(IPTp), long-lasting insecticide-treated bed nets (LLINs)),
comparison against the extended 2030 global targets [87]
(50% reduction in the number of stunted children, wasting
in children < 3%, 50% reduction on anaemia in women);
and sub-analyses for low-income, lower-middle-income
and upper-middle-income countries.
Results
The estimated 2018 prevalence of undernutrition de-
rived for the 129 countries varied significantly by coun-
try and indicator, but was generally highest in south and
central Africa (Fig. 1). Under-five stunting prevalence
was highest in Burundi at 57% (global average 25%),
under-five wasting prevalence was highest in South
Sudan at 24% (global average 6%) and anaemia




[Between countries: median; inter-quartile
range (IQR) and range between countries]
Low income country (LC), lower-middle
income country (LMC) and upper-middle
income country (UMC) averages
Sources and notes
countries. We assume 0 percent if fortification legislation is
in the planning stages, 25 percent for voluntary status, and
50 percent if mandatory fortification is legislated.”, citing [71,
72]
Iron and iodine fortification
of salt




47% [Between countries: median=54.9%; IQR=16.2-
73.9%; range=0-96.7%]
LC average=62%, LMC average=39.6%, UMC
average=15%
DHS [37]/LiSTa [34]; only includes countries with malaria risk.
aLiST states “Coverage data for this indicator are drawn from DHS, MICS, and other nationally representative household surveys.”
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[Between countries: median; IQR and range
between countries]
Low income country (LC), lower-middle income
country (LMC) and upper-middle income country
(UMC) averages
Sources and notes for calculating commodity and
human resource cost components. Commodity
costs have been marked up to include supply




US$351.41 [Between countries: median=US$286.06; IQR=
US$103.97-521.91; range=US$23.74-1182.46]
LC average=US$63.22, LMC average=US$230.15, UMC
average=US$653.16




US$2.03 [Between countries: median=US$1.1; IQR=US$0.38-
2.79; range=US$0.03-12.85]
LC average=US$0.4, LMC average=US$1.4, UMC
average=US$3.6
Cost per birth. Assumes 5 minutes of specific health
provider time per caseb and nurses/midwives receive
training every 5 yearsc.
Infant and young child
feeding education
US$8.12 [Between countries: median=US$6.63; IQR=US$2.49-
12; range=US$0.66-27.03]
LC average=US$1.6, LMC average=US$5.4, UMC
average=US$15
Cost per child per annum. Country-specific estimates
calculated by scaling the cost interval from Shekar et
al. investment framework for nutrition [24] according
to the range of per capita GDP for the 129 countries.
i.e., the lowest cost estimate from Shekar et al. is
assumed to be for the country with the lowest GDP
per capita, the highest cost estimate for the country
with the highest GDP per capita, and cost estimates
for each country in between are scaled according to
where their GDP per capita falls in the range between
the lowest and highest values.
Immediate initiation of
breastfeeding
US$21.71 [Between countries: median=US$11.88; IQR=US$3.29-
28.26; range=US$0.31-143.79]
LC average=US$3.9, LMC average=US$14.5, UMC
average=US$40.1
Cost per preterm birth. Assumes 60 minutes of specific
health provider time per preterm birth + and nurses/
midwives receive training every 5 yearsc.
Lipid-based nutrition
supplements
US$23.71 [Between countries: median=US$23.28; IQR=
US$22.58-24.22; range=US$21.46-29.75] LC average=
US$25.3, LMC average=US$23.1, UMC average=
US$23.3
Cost per annum. Commodity costs (US$10, assuming
1/3 sachets/day for 100 days at US$45 for 150 SQ-LNS
sachets of 92g9) + 18 minutes of specific health
provider time per annum (assumed to be the same as
for micronutrient powders) [74].
Oral rehydration solution
+ Zinc
US$2.06 [Between countries: median=US$2; IQR=US$1.91-2.16;
range=US$1.72-2.69]
LC average=US$2, LMC average=US$1.9, UMC
average=US$2.2
Cost per diarrhoea episode. Commodity costs (US$0.77
[74]) + 10 minutes of specific health provider time per
case of diarrhoea [74].
Public provision of
complementary foods
US$104.48 [Between countries: median=US$94.96; IQR=
US$68.46-129.3; range=US$56.78-225.46] LC average=
US$62.5, LMC average=US$86.8, UMC average=
US$148.4
Cost per child per annum. Country-specific estimates
calculated by scaling the cost interval from Shekar et
al. investment framework for nutrition (2017) [24] as for
IYCF education.
Treatment of SAM US$246.99 [Between countries: median=US$221.47; IQR=
US$187.37-288.85; range=US$86.91-972.69]
LC average=US$185.8, LMC average=US$246.3, UMC
average=US$288
Cost per case. Commodity costs (US$44.60 for material
costs on averaged, and assuming complicated cases
require an average of 14 days, inpatient care was
costed according to regional estimates from WHO-
CHOICE unit costs of patient services [75]) + 200
minutes of specific health provider time per case of
SAM on averaged. All treatment assumptions are based
upon Bhutta et al. (2013)12.
Vitamin A
supplementation
US$1.36 [Between countries: median=US$1.13; IQR=US$0.57-
1.89; range=US$0.33-4.01]
LC average=US$0.5, LMC average=US$1, UMC
average=US$2.3
Cost per child per annum. Commodity costs (US$0.10
[74]) + 18 minutes of specific health provider time per
annum from the OneHealth tool [74].
Balanced energy-protein
supplementation
US$54.01 [Between countries: median=US$49.84; IQR=
US$38.23-64.89; range=US$33.11-107.02] LC average=
US$35.6, LMC average=US$46.3, UMC average=
US$73.3
Cost per pregnancy. Country-specific estimates
calculated by scaling the cost range from Shekar et al.




US$42.51 [Between countries: median=US$40.65; IQR=
US$39.94-44.62; range=US$39.44-54.75] LC average=
US$46.8, LMC average=US$41.9, UMC average=
US$40.3
Cost per pregnancy. Commodity costs (US$18.60,
assuming 1.5g/day for 6 months15 at US$0.02/0.3g
tablet [76]) + 8 minutes total health provider time per
pregnancy [74].
Iron and folic acid US$13.78 [Between countries: median=US$13.56; IQR= Cost per pregnancy. Commodity costs (US$5.88 [76])
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prevalence among women was highest in Yemen at 71%
(global average 29%).
Under the status quo (i.e. no change to current
trends), 46 (34%) of the 129 countries were on track to
achieve a 40% in reduction in stunting by 2025, 66 (51%)
were on track to reduce wasting to below 5% by 2025
and 0 (0%) were on track to reduce anaemia by 50% by
2025.
Scaling up all 18 nutrition interventions to 95% cover-
age reduced the cumulative number of children reaching
age five stunted or wasted between 2019 and 2030 by
42.1 million and 13.8 million respectively, and averted
476 million cases of anaemia. With all interventions
scaled up, the global number of children under five who
were stunted in 2030 was 20% lower than the status quo
scenario in 2030, and the prevalence of wasting in chil-
dren and anaemia in women in 2030 were reduced by an
average of 14% and 22%, respectively, compared to 2030
prevalence in the status quo scenario. With all interven-
tions scaled up, an additional 4, 17 and 7 countries were




[Between countries: median; IQR and range
between countries]
Low income country (LC), lower-middle income
country (LMC) and upper-middle income country
(UMC) averages
Sources and notes for calculating commodity and
human resource cost components. Commodity
costs have been marked up to include supply




US$13.07-14.17; range=US$12.57-17.44] LC average=
US$14.8, LMC average=US$13.5, UMC average=
US$13.4
for 1 tablet per day for 6 months + 8 minutes of
specific health provider time per pregnancy [74].
Assumes supplied through community health facilities.




US$1.45 [Between countries: median=US$1.31; IQR=US$1.16-
1.63; range=US$1.02-2.58]
LC average=US$1.1, LMC average=US$1.3, UMC
average=US$1.8
Cost per woman per annum. Commodity costs
(US$0.42 [76]) for 1 tablet per week for 3 months + 8
minutes of specific health provider time per pregnancy





US$0.66 [Between countries: median=US$0.6; IQR=US$0.29-
0.96; range=US$0.18-1.54]
LC average=US$0.2, LMC average=US$0.4, UMC
average=US$1
Cost per pregnancy. Commodity costs (US$0.06 [74]) +
8 minutes specific health provider time per pregnancy
[74].
Intervention only applies to countries with malaria risk.
Multiple micronutrient
supplementation
US$19.72 [Between countries: median=US$19.34; IQR=
US$18.64-20.45; range=US18.11-25.16]
LC average=US$21.46, LMC average=US$19.33, UMC
average=US$18.94
Cost per pregnancy. WHO regional commodity costs
(US$5.52-7.21 [10]) + 8 minutes of specific health
provider time per pregnancy [74]
Iron and folic acid
fortification (wheat,
maize or rice)
US$0.37 Cost per person per annum. Global estimate for wheat
flour from Shekar et al. investment framework for
nutrition [24] and Horton (2006) [77].
Iron and iodine
fortification of salt




US$4.57 [Between countries: median=US$4.51; IQR=US$4.28-
4.73; range=US$4-5.71]
LC average=US$4.9, LMC average=US$4.5, UMC
average=US$4.4
Cost per person per annum. Commodity costs
(US$5.26/3 years [76]) + 5 minutes personnel time for
delivery [10]. Long-lasting insecticide-treated bed nets
are assumed to last 3 years, so the purchasing cost is
$13.05 [$12.37, IQR: $12.10-13.82, range: $11.82-16.88]
Intervention only applies to countries with malaria risk.
Abbreviations: DHS Demographic and Health Survey, GDP gross domestic product, IQR inter-quartile range, IYCF infant and young child feeding, LC low income
country, LiST Lives Saved Tool, LMC lower-middle income country, MAM moderate acute malnutrition, OR odds ratio, ORS oral rehydration solution, RRR relative
risk ratio, SGA small for gestational age, SAM severe acute malnutrition SQ-LNS small quantity lipid nutrient supplement paste, UMC upper-middle income country,
WHO-CHOICE World Health Organization CHOosing Interventions that are Cost-Effective
aCountry-specific supply chain costs were estimated similarly to Stenberg and colleagues’ [78], who grouped 73 countries into five categories based on “Logistics
System Condition”, and estimated a mark-up percentage to apply to commodities for countries in each group. Additional countries in this study were allocated
into the five groups by determining an approximate range of GDP per capita for each group (higher GDP per capita is assumed to be associated with better
logistics system conditions)
b Hourly (and per minute) wages for staff time estimated for each country by taking per capita GDP, and dividing by an assumed 48 weeks worked per year, and
38 hours worked per week
cTraining was assumed to cost US$300 per session, with a session educating 10 nurses/midwives every five years. The annual cost per nurse/midwife (US$6) was
translated to a per-birth cost by estimating the number of births per nurse/midwife per year: the total number of births1 divided by the estimated number of
nurses/midwives in the country2
dAll patients are assumed to receive amoxicillin for 5 days (1.5 x 250mg/day at US$0.02/250mg [76]); 15% of cases are assumed to be complicated, requiring
inpatient care and receiving 7 days of F-75 therapeutic milk (700mL/day with approximately 2.5L reconstituted milk per 400g carton at US$61.20 per case of 24
cartons [79]). Furthermore, half of complicated cases are assumed to require an additional 14 days of inpatient care and F-100 therapeutic milk (1.4L/day with
approximately 2.1L reconstituted milk per 400g carton at US$70.50 per case of 24 cartons [79]). All uncomplicated cases and half of complicated cases also receive
15kg of RUTF over 8 weeks (US$45 for 150 LNS sachets of approximately 100g [75]). For accounting personnel time, uncomplicated cases plus half of complicated
cases are assumed to require 10 minutes/week for 8 weeks, and all complicated cases require 60 minutes/day for an average of 14 days
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projected to reach the stunting, wasting and anaemia
targets respectively (Fig. 2, with projected stunting
prevalence in Fig. 3).
Scaling up all interventions was estimated to cost an
additional $458 billion between 2019 and 2030; however,
the majority of the total possible impact came from only
a few interventions (Fig. 4). At an aggregate global level,
the model estimated that scaling up IPTp (in regions
with malaria), infant and young child feeding (IYCF)
education, vitamin A supplementation and lipid-based
nutrition supplements produced 88% of the total global
impact on stunting and cost US$19.75 billion between
2019 and 2030, with average costs per case averted of
US$103, US$267, US$556 and US$1795 when interven-
tions were consecutively added, respectively (Table 4). In
a sensitivity analysis, we estimate that if IYCF were more
than 2.1 times our unit cost estimate, then the order of
IYCF and vitamin A supplementation would be reversed.
Country-specific estimates are provided in Additional
file 2.
At an aggregate global level, scaling up vitamin A sup-
plementation and cash transfers produced 100% of the
total impact on wasting and cost US$275.97 billion be-
tween 2019 and 2030 (predominantly for cash transfers),
with average costs per case averted of US$1989 and
US$19,427 when interventions were consecutively added,
respectively (Table 4). Note that while the treatment of se-
vere acute malnutrition (SAM) intervention is effective at
preventing mortality from wasting, in the model it had no
impact on wasting prevalence (Table 1 and “Discussion”).
At an aggregate global level, scaling up IPTp, iron and
folic acid (IFA) supplementation for non-pregnant
women, multiple micronutrient supplementation for
pregnant women produced 89% of the total impact on
anaemia and cost US$16.98 billion between 2019 and
2030, with average costs per case averted of US$9,
US$35, US$47, US$71 and US$194 when interventions
were consecutively added, respectively (Table 3). Iron
fortification of salt and iron and folic acid fortification of
staple foods were the next most cost-effective for redu-
cing anaemia.
There were important differences between countries
as to which interventions were the most cost-effective,
which were driven largely by differences in the data in-
puts such as risk of malaria (countries without malaria
receive no benefit from IPTp or LLINs), prevalence of
breastfeeding (higher breastfeeding prevalence reducing
the impact of IYCF education), incidence of diarrhoea
Fig. 1 Estimated 2018 prevalence of stunting in children under 5 (top left), wasting in children under 5 (top right) and anaemia in women of
reproductive age (bottom left)
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(less diarrhoea meaning reduced impact of vitamin A
supplementation), the proportion of small and preterm
births (smaller impact of supplements for pregnant
women) and unit cost assumptions. However, despite
differences in the prioritisation of interventions between
settings, the finding that the majority of the total impact
came from a select few interventions remained true.
Sub-analyses indicate that the majority of the cost and
impact is in low-income countries, rather than lower-
middle- or upper-middle-income countries (Table 5,
based on World Bank classifications). Similar results
were found when progress was assessed against the 2030
targets. If only nutrition-specific interventions were in-
cluded in the analysis (i.e. excluding cash transfers, IPTp,
LLINs), then a smaller impact was achieved, particularly
for wasting and anaemia, highlighting the benefits of
these interventions.
Discussion
Using the Optima Nutrition model, scaling up 18
evidence-based nutrition interventions to 95% coverage
across 129 countries could lead to 42 million fewer
stunted children between 2019 and 2030 and a 20% re-
duction in the number of children stunted in 2030, and
reduce the 2030 prevalence of wasting in children and
anaemia in women by an average of 14% and 22% re-
spectively. This work expands previous analyses by iden-
tifying a subset of interventions that are the most cost-
effective and contribute the greatest impact towards the
SDG undernutrition indicators; these interventions
should be prioritised in the context of limited financial
resources. These models also highlight the need to con-
sider a broader set of interventions to address food sys-
tems and social determinants of health in order to reach
the SDG targets, for example agriculture interventions
and interventions for poverty alleviation, food security,
WASH and women’s empowerment. This is consistent
with previous studies that have recognised the that
nutrition-specific interventions alone will not help coun-
tries reach SDG targets, highlighting the need for invest-
ments in evidence-based nutrition-sensitive interventions
[5, 10, 18, 23, 24, 88].
For reducing stunting, IPTp, IYCF education and vita-
min A supplementation were the most cost-effective in-
terventions globally. IPTp can lead to improved birth
outcomes in areas with malaria risk [66], therefore redu-
cing stunting risk, but it was its low cost rather than
high impact that made it the most cost-effective
Fig. 2 Countries that are projected to reach targets under that status quo (green), in the maximum impact scenario (orange) or not at all (red).
Panels show targets for stunting in children under five (top left), wasting in children under five (to-right) and anaemia in women of reproductive
age (bottom left)
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intervention—even at high coverage it produced limited
total gains. IYCF education can improve breastfeeding
and complementary feeding behaviours [45], which can
reduce diarrhoea [45] and stunting [89]. Importantly,
relevant and high-quality education must be delivered
that includes support for breastfeeding at a local and na-
tional level, combined with enabling activities such as
countries implementing WHO codes for breast-milk
substitutes [90]. The next most cost-effective interven-
tion for stunting was vitamin A supplementation [91].
Vitamin A supplementation has been implemented at
scale in many countries already to both reduce mortality
and prophylactically reduce diarrhoea incidence, and this
study provides evidence to continue expansion of this
intervention to countries where this is not already the
case.
For reducing wasting, vitamin A supplementation
was identified as the most cost-effective intervention.
Vitamin A supplementation can reduce diarrhoea in-
cidence, a risk factor for wasting, and is therefore
preventative. While the treatment of SAM interven-
tion is effective at preventing mortality from wasting
[10, 59], in the model it had no impact on wasting
prevalence. This is because the intervention is defined
as treating children until they reach a weight-for-
height of three standard deviations below the WHO
Child Growth Standards median, at which point their
mortality risks are significantly reduced but they are
still defined as being wasted for purposes of the SDG
target (i.e. children who are severely wasted are
treated to become only moderately wasted, but wasted
nonetheless). Cash transfers were identified as the
next most cost-effective intervention, but with a cost
per case averted six times higher than vitamin A sup-
plementation. Cash transfers is an example of a social
protection intervention primarily intended to help
households meet basic needs; however, this study pro-
vides evidence of its potential benefit for nutrition.
For anaemia, it is not surprising that IPTp, IFAS for
non-pregnant women and multiple micronutrient
Fig. 3 Projected changes to nutrition indicators under the status quo and maximal impact scenarios for individual countries. Boxplots show the
median and inter-quartile range of indicators across countries, with tails representing the maximum and minimum values. The red line represents
the relevant 2025 target at a global level. a Stunting prevalence among children under five. b Wasting prevalence among children under five. c
Anaemia prevalence among women of reproductive age. Abbreviations: IQR, inter-quartile range; WRA, women of reproductive age
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supplements for pregnant women were the most cost-
effective given their low unit costs and high impacts
(Table 1).
The results of this study are consistent with previ-
ous work, but expand the intervention and country
sets, and also consider intervention prioritisation.
Other studies have estimated that scaling up subsets
of these 18 nutrition interventions could lead to ap-
proximately a 20% reduction in stunting in children
[23, 24] (~ 65 million cases averted globally [24]). The
consistency of impact projections is not surprising be-
cause the effect estimates for interventions (Table 1),
as well as the causal pathways and risk factors used
in the Optima Nutrition model (Figure A2), are based
on the same evidence base as other models used for
these analyses (e.g. LiST [92, 93]). A recent study also
estimated that 45% and 35% of 105 LMICs analysed
were likely to reach the stunting and wasting targets re-
spectively [94], which is consistent with our analysis if we
constrain to the same set of countries. Our cost estimate
of approximately $42 billion per annum to scale up all 18
interventions was more than previous estimates ($10.3 bil-
lion [23] and $9.6 billion [10] per annum, and $70 billion
over 10 years [24]), because, as well as including additional
high-cost interventions (e.g. cash transfers), our unit costs
are up to twice as high due to the fractional costs associ-
ated with infrastructure and health system strengthening.
Where comparisons are available, the cost-effectiveness
estimates for individual interventions are approximately in
line with World Bank estimates (e.g. $266 and $467 per
stunting case averted for vitamin A and IYCF education
respectively [24], and $10–62 per anaemia case averted
with IPTp and micronutrient supplements for women
[24]).
Fig. 4 Cost-effective expansion pathway for reducing the prevalence of stunting in children under five (top left), wasting in children under five
(top right) and anaemia in women of reproductive age (bottom left). The additional cost and impact at sequential steps are calculated by taking
continued status quo outcomes 2019–2030 aggregated over all countries, and sequentially increasing intervention coverage in all countries from
baseline to 95% over a 5-year period (2019–2024). Variations in prioritisation exist for individual countries (Additional file 2). Maximum impact is
the total cases averted across all countries when all 18 interventions were scaled up simultaneously. Abbreviations: IFA, iron and folic acid; IFA
supp., iron and folic acid supplementation; IPTp, intermittent preventative treatment of malaria during pregnancy; IYCF, infant and young child
feeding; LNS, lipid-based nutrition supplements; MMS, multiple micronutrient supplementation; PW, pregnant women
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Between countries, different intervention priorities
may be needed based on differences in baseline nutri-
tion indicators, baseline intervention coverages, inter-
vention effect sizes and intervention costs. In this
analysis, effect estimates for interventions and baseline
intervention coverage did not have an impact on
between-country variation in cost-effectiveness. This
is because intervention effect sizes were assumed to
apply across all settings, a limitation of this study due
to lack of evidence indicating otherwise, and because
a linear cost-coverage relationship was used, meaning
that baseline intervention coverage affected the im-
pact that could be achieved with further scale-up but
not cost-effectiveness. In this analysis, country-specific
unit costs were calculated for interventions; however,
between countries the intervention costs were largely
scaled in proportion to one another (e.g. the human
resource component costs were scaled according to
the GDP) meaning that the relative costs were gener-
ally unchanged. Therefore, the greatest driver of
between-country differences was baseline nutrition in-
dicators, highlighting the importance of tailoring in-
terventions to target areas or risk factors that drive
the greatest burden (e.g. IYCF education was a higher
priority in settings with lower baseline breastfeeding
prevalence).
Major areas of current and future research are to de-
fine a broader set of interventions that can indirectly im-
prove nutrition indicators, and to quantify their costs
and benefits. For example, there is evidence that animal-
sourced foods may reduce stunting [95, 96], but there
are limited studies linking agriculture and food system
interventions to changes in nutritional indicators. Ad-
dressing the known underlying determinants of under-
nutrition is also critical. For example, improving gender
equity and ensuring women can choose when and how
many children they have can improve financial security
and reduce poverty [97, 98], both of which are correlated
with poor nutritional outcomes. However, defining inter-
ventions to empower women and quantifying their effect
sizes, which will be highly context specific, remains a
challenge.
Implications of the COVID-19 pandemic
The COVID-19 pandemic is expected to have profound
impacts on countries’ ability to achieve the SDG targets
[99]. Recent estimates suggest that globally there could
be a 14.3% increase in the prevalence of moderate or se-
vere wasting among children under five in 2020, or 6.7
million additional children with wasting, compared with
projections for 2020 without COVID-19 [100]. The im-
plications for stunting are less clear, as it is a chronic
condition and would therefore depend on the duration
of the pandemic and associated disruptions.
In this study, the subset of interventions identified as
the most cost-effective is based on pre-COVID-19 esti-
mates of nutrition indicator trends, baseline intervention
coverages and intervention unit costs. In particular, short-
term changes to the unit costs (e.g. if commodities are
more difficult to procure, if there are additional personal
protective equipment costs or if services are delivered dif-
ferently), if large enough and disproportionate across in-
terventions, may lead to changes in the prioritisation of
interventions. Further work is required to identify how to
prioritise interventions to address the acute impacts of
COVID-19, and this is currently being undertaken by the
Standing Together for Nutrition consortium [101]. Once
the immediate impacts of COVID-19 are managed, costs
may revert to pre-pandemic levels, but at this point, we
cannot predict when this will occur.
Table 5 Model sub-analysis projections for the number of countries reaching the SDG 2.2 targets. Each row represents the
maximum impact scenario, where interventions are scaled up to 95% coverage in each country over a five-year period. The main
analysis row is the same as the results presented above, and other rows are sensitivity analyses





Stunting Wasting Anaemia Stunting Wasting Anaemia
Main analysis 50/129 83/129 7/129 42,106,000 13,783,000 476,304,000 US$458
No nutrition-sensitive interventions
(i.e. excluding cash transfers, IPTp, LLINs)
49/129 70/129 4/129 41,323,000 806,000 436,170,000 US$155
2030 targets instead of 2025 targets 8/129 53/129 7/129 42,106,000 13,783,000 476,304,000 US$458
Low income countries only 9/33 18/33 2/33 12,172,000 3,641,000 94,488,000 US$58
Lower-middle income countries only 15/46 25/46 1/46 24,917,000 9,550,000 274,880,000 US$244
Upper-middle income countries only 26/50 40/50 4/50 5,017,000 592,000 106,936,000 US$156
Interventions scaled up over 10 years
instead of 5 years
44/129 74/129 7/129 29,007,000 10,122,00 355,187,000 US$337
Abbreviations: IPTp Intermittent preventative treatment of malaria during pregnancy, LLINs long-lasting insecticide-treated bednets, SDG Sustainable Development
Goal
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Limitations
This study has a number of limitations. The effect sizes
of interventions may be overestimated as they were
taken from meta-analyses that included an overrepresen-
tation of randomised controlled trials. The modelled
impact is therefore based on the assumption that inter-
ventions could be implemented as effectively observed in
controlled conditions, and delivered precisely to their
target populations, which is not likely to be the case.
Therefore, our lower-bound estimates, which were de-
rived from the lower-bound impact estimates, may be
closer to the actual achievable impact when accounting
for loss of effectiveness when moving from trials to
scaled up programmes. Effect estimates were assumed to
apply across all settings, due to lack of evidence indicat-
ing otherwise, but in reality, some populations will re-
spond to them differently. We did not assume any
complementary effects of interventions when imple-
mented together, and applied consecutive independent
relative reductions, but it is unclear whether there are
cumulative benefits (or diminishing returns) to layering
interventions.
It is unclear how feasible it would be to scale some of
these interventions to high coverage, particularly within
5 years. The coverage of interventions was assumed to
be constant in the status quo, but may naturally increase
as health systems are strengthened, which would mean
we have overestimated the impact of scaling up these in-
terventions (but the cost-effectiveness would remain as
estimated). Similarly, changes in projected populations
sizes, GDP growth, poverty and other indicators may in-
fluence the baseline (status quo) projection, and hence
the results. Where no intervention coverage data was
available, we assumed a baseline zero coverage, which
would also mean we have overestimated the impact of
scale-up if some coverage already existed.
There are limitations to the model structure. For ex-
ample, the model is based on the risk factor structure /
causal pathway outlined in Figure A2 based on evidence
available to support and quantify each relationship. Op-
tima Nutrition is a global model and as such relies on a
high threshold of evidence for interventions and/or risk
factors to be included (i.e. typically meta-analyses of ran-
domised controlled trials). This means that some inter-
ventions, particularly those that impact risk areas not in
Figure A2, may be being overlooked where trial data are
unpublished or no meta-analysis exists because few pub-
lished trials are available.
While costing studies exist for selected interventions
in selected countries, nothing is currently available at
a global level that could be adapted across the 129
settings that were modelled. Therefore, we generated
simple unit cost estimates that attempted to include
the different costing domains, but individual country-
specific costing studies could more precisely account
for staffing, infrastructure, logistic and other overhead
costs and improve the accuracy of cost and cost-
effectiveness estimates. We also assumed that the unit
costs of interventions would remain constant with
scale, which may not be the case as economies of
scale may reduce marginal costs as coverage increases
and saturation effects may decrease marginal costs as
coverage becomes high.
Population and epidemiological data inputs came
largely from global data sets, and for some countries,
this required imputing regional values or using modelled
data where estimates were missing. This also does not
account for differences within each country by geo-
graphic location or wealth quintile, or temporal differ-
ences such as seasonality that may be associated with
wasting but not captured in DHS or MICS surveys as a
result of survey timing. In the main results, we have
rolled-up country estimates to derive global progress;
however, there is a great deal of subnational variation in
progress and our supplementary results may be more
useful for individual countries than whether or not glo-
bal targets are reached.
Conclusions
Of the 129 countries modelled, 46 (34%) were on track
to achieve a 40% in reduction in stunting by 2025, 66
(51%) were on track to reduce wasting to below 5% by
2025, and 0 (0%) were on track to reduce anaemia by
50% by 2025. Scaling up 18 nutrition interventions glo-
bally could reduce stunting, wasting and anaemia by
20%, 14% and 22% respectively, and increase the number
of countries on track to achieve the SDG 2.2 targets to
50 (39%), 83 (64%) and 7 (5%) respectively. The majority
of the total impact was the result of only nine interven-
tions, which suggests that they should be prioritised in
the context of limited budgets.
Supplementary information
Supplementary information accompanies this paper at https://doi.org/10.
1186/s12916-020-01786-5.
Additional file 1. Detailed model description and additional model
parameters.
Additional file 2. Country-specific model inputs and country-specific
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